Skip to Content

Naloxone Injection

Last Updated: July 29, 2013
Status: Resolved

Products Affected - Description

Naloxone 0.4 mg/mL Injection, Hospira

Reason for the Shortage

  • Endo discontinued its Narcan 0.02 mg/mL 2 mL ampules, 1 mg/mL 10-mL multidose vial, and 2-mL ampule presentations in 2005. The company discontinued their 0.4 mg/mL presentations September, 2006. Endo would not provide a reason for the discontinuations.
  • Abbott discontinued naloxone 0.02 mg/mL 2 mL ampules and vials in 2001. The company would not provide a reason for the discontinuation.
  • There are no manufacturers of naloxone 0.02 mg/mL strength.
  • Hospira had naloxone on shortage due to manufacturing delays.
  • Amphastar changed NDC numbers in spring, 2012.

Available Products

Naloxone 1 mg/mL Injection, Amphastar
2 mL Mini-I-Jet syringes with needles (NDC 76329-1469-05)
2 mL Luer-Jet syringes without needles (NDC 76329-3369-01)

 
Naloxone 0.4 mg/mL Injection, Hospira
1 mL vials (NDC 00409-1215-01)
1 mL Carpuject syringe (NDC 00409-1782-69)
10 mL vials (NDC 00409-1219-01)

Estimated Resupply Dates

Hospira and Amphastar have all presentations readily available.   

Updated

July 29, 2013; May 30, 2013; April 23, 2013; March 5, 2013; January 21, 2013; December 21, 2012; December 10, 2012; November 19, 2012; October 11, 2012; October 5, 2012; September 28, 2012; August 16, 2012; July 3, 2012; June 27, 2012; June 4, 2012; May 24, 2012; May 18, 2012; May 14, 2012; May 10, 2012; April 11, 2012; March 29, 2012; March 8, 2012; February 10, 2012; December 13, 2011; November 15, 2011; October 31, 2011; October 20, 2011; October 11, 2011; September 27, 2011; September 2, 2011, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide